Patents by Inventor NEERAJ ADYA

NEERAJ ADYA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220363760
    Abstract: The present disclosure provides methods of identifying a subject suitable for an immunooncology (I-O) therapy comprising measuring the expression of one or more genes of a pantumor inflammation gene panel. In some aspects, the method further comprises administering an I-O therapy to the subject. In some aspects, the I-O therapy comprises administering an anti-PD-1 antibody or antigen-binding portion thereof or an anti-PD-L1 antibody or antigen-binding portion thereof to the subject.
    Type: Application
    Filed: May 29, 2020
    Publication date: November 17, 2022
    Applicant: Bristol-Myers Squibb Company
    Inventors: Peter M. SZABO, Lan ZHANG, Keyur H. DESAI, Neeraj ADYA, Zhenhao QI, Kim ZERBA, Scott Adams ELY, Saumya PANT, George A. GREEN
  • Publication number: 20220259669
    Abstract: The present disclosure provides methods of identifying a subject suitable for an immunooncology (I-O) therapy comprising measuring the expression of one or more of STAT1, IFN?, NECTIN2, and CSFIR. In some aspects, the I-O therapy comprises administering an anti-PD-1 antibody or antigen-binding portion thereof or an anti-PD-L1 antibody or antigen-binding portion thereof to the subject.
    Type: Application
    Filed: May 29, 2020
    Publication date: August 18, 2022
    Applicant: Bristol-Myers Squibb Company
    Inventors: Peter M. SZABO, Lan ZHANG, Keyur H. DESAI, Neeraj ADYA, Zhenhao QI, Alex GREENFIELD, George C. LEE, Scott Adams ELY, Saumya PANT, George A. GREEN
  • Publication number: 20220233691
    Abstract: The present disclosure provides methods of identifying a subject suitable for an immuno-oncology (I-O) therapy comprising measuring the expression of one or more of STAT1, IFN?, NECTIN2, and CSF1R. In some aspects, the I-O therapy comprises administering an anti-PD-1 antibody or antigen-binding portion thereof or an anti-PD-L1 antibody or antigen-binding portion thereof to the subject.
    Type: Application
    Filed: May 29, 2020
    Publication date: July 28, 2022
    Applicant: Bristol-Myers Squibb Company
    Inventors: Peter SZABO, Lan ZHANG, Keyur H. DESAI, Neeraj ADYA, Zhenhao QI, Alex GREENFIELD, George C. LEE, Scott Adams ELY, Saumya PANT, George A. GREEN
  • Publication number: 20180371543
    Abstract: The present invention relates to compositions and methods for detection, analysis, and treatment of nucleic acids. In particular, the present invention relates to compositions and methods for generating and using hybridization probes.
    Type: Application
    Filed: July 24, 2018
    Publication date: December 27, 2018
    Inventors: John Russell, Ekaterina Pestova, Neeraj Adya
  • Patent number: 10030268
    Abstract: The present invention relates to compositions and methods for detection, analysis, and treatment of nucleic acids. In particular, the present invention relates to compositions and methods for generating and using hybridization probes.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: July 24, 2018
    Assignee: ABBOTT MOLECULAR INC.
    Inventors: John Russell, Ekaterina Pestova, Neeraj Adya
  • Publication number: 20160215334
    Abstract: The present invention relates to compositions and methods for detection, analysis, and treatment of nucleic acids. In particular, the present invention relates to compositions and methods for generating and using hybridization probes.
    Type: Application
    Filed: November 11, 2015
    Publication date: July 28, 2016
    Inventors: JOHN RUSSELL, EKATERINA PESTOVA, NEERAJ ADYA